Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLC
The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2010 by Aptium Oncology Research Network.
Recruitment status was Active, not recruiting
Recruitment status was Active, not recruiting
Sponsor:
Aptium Oncology Research Network
Collaborator:
Millennium Pharmaceuticals, Inc.
Information provided by:
Aptium Oncology Research Network
ClinicalTrials.gov Identifier:
NCT00516100
First received: August 10, 2007
Last updated: January 14, 2010
Last verified: January 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | August 2012 |
| Estimated Primary Completion Date: | January 2010 (Final data collection date for primary outcome measure) |